Filing Details
- Accession Number:
- 0001209191-17-065461
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-13 16:52:20
- Reporting Period:
- 2017-12-11
- Accepted Time:
- 2017-12-13 16:52:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1567514 | Intra-Cellular Therapies Inc. | ITCI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1316274 | A Richard Lerner | C/O Intra-Cellular Therapies, Inc. 430 East 29Th Street New York NY 10016 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-12-11 | 12,500 | $1.50 | 60,000 | No | 4 | M | Indirect | Held by the Lerner Family Trust UAD 11/14/94 |
| Common Stock | Disposition | 2017-12-11 | 7,000 | $15.09 | 53,000 | No | 4 | S | Indirect | Held by the Lerner Family Trust UAD 11/14/94 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Indirect | Held by the Lerner Family Trust UAD 11/14/94 |
| No | 4 | S | Indirect | Held by the Lerner Family Trust UAD 11/14/94 |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2017-12-11 | 12,500 | $0.00 | 12,500 | $1.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-12-12 | No | 4 | M | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 8,621 | Direct |
Footnotes
- Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein.
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. The proceeds from this sale will be used primarily to cover the reporting person's tax liability arising from the exercise of the option.
- The shares were sold at prices ranging from $14.97 to $15.24. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- All shares underlying this option have vested.
Billionaire Hedge Funds
